Tuberc Respir Dis.  1974 Mar;21(1):19-24. 10.4046/trd.1974.21.1.19.

Cost-benefit Analysis of Tuberculosis Control Program in Korea

• KMID: 2529029
• DOI: http://doi.org/10.4046/trd.1974.21.1.19

Abstract

Through the cost-benefit analysis of the Tuberculosis Control Program in Korea and on the basis of available statistical data and the resultant estimates concerning the economic loss incurred by tuberculosis morbidity and mortality the following conclusion has been reached: 1. The economic loss resulting from tuberculosis mobidity and mortality reached a total of 44. 31 billion won in the year of 1970. This amount broke down into 3.31 billion in medical care expenditure, 25.88 billion in decrease in income incurred by infection of the disease, and 15. 12 billion in loss resulting from tuberculosis mortalities. (Refer to Table 8.) 2. The yearly ratio of cost to benefit were 24.1 to 36. 1 in 1965, 27. 1 to 95.8 in 1966, 39. 5 to 173. 2 in 1967, 67. 7 to 296. 0 in 1968, and 87.9 to 456. 8 in 1969. The benefit from the tuberculosis control program amounted to a total of 105.79 billion won while the total cost reached 24. 63 billion won. The ratio of gross benefit to the total cost was thus 429.5 percent. (Refer to Table 11.) 3. The cost (X) and benefit (Y) of the tuberculosis control program for the five-year period of 1965 to 1969 are indicated by means of a linear regression equation as: Y=-82. 5+5. 97X. In other words, benefit amounted, so to speak, to 5. 97 for 1 in cost. (Refer to Fig. 1.)